The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Frequency of HCV infection in renal cell carcinoma patients.
B. Budakoglu
No relevant relationships to disclose
S. Aksoy
No relevant relationships to disclose
C. Arslan
No relevant relationships to disclose
U. Uyeturk
No relevant relationships to disclose
N. A. Babacan
No relevant relationships to disclose
M. F. Ozcan
No relevant relationships to disclose
R. Yildiz
No relevant relationships to disclose
B. B. Oven
No relevant relationships to disclose
N. Ozdemir
No relevant relationships to disclose
O. Dizdar
No relevant relationships to disclose
S. Buyukberber
No relevant relationships to disclose
M. B. Akinci
No relevant relationships to disclose
I. Turker
No relevant relationships to disclose
O. B. Oksuzoglu
No relevant relationships to disclose
M. K. Altundag
No relevant relationships to disclose
N. Zengin
No relevant relationships to disclose